We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:TRVI
​
​
logo

Trevi Therapeutics (TRVI)

Nasdaq • TRVI • US89532M1018

12.81Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 12.9% of free float sold short, 5.3 days to cover, cost to borrow 0.44%. Sign up for live short interest data.

Market Cap

1.83b USD | # 4052 in US

Volume

1.93m shares | 29.38m USD

Shares Outstanding

142.48m

Free Float Shares

83.05% | 118.32m

News

TRVI key data

Trevi Therapeutics (Nasdaq: TRVI) has a market capitalization of $1.83B. Last close $12.81 (as of 2026-11-06); 52-week range $9.82 to $20.22. ORTEX data as of 2026-10-22: short interest was 12.93% of free float, 5.3 days to cover and the average cost to borrow was 0.44%. Sign up for live short interest data.

  • TRVI news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.